SEC Form 4 · accession 0001387131-15-003677
TherapeuticsMD, Inc. · TXMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mitchell Krassan
Officer — EVP, Chief Strategy Officer
Period of report
Dec 17, 2015
Accepted (ET)
Dec 21, 2015 · 8:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000025743
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F1 | $8.92 | Dec 17, 2015 | A | 150,000 | A | Jan 17, 2016 | Dec 17, 2025 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1The option vests in equal monthly installments over 12 months.